ORI Capital: A global venture capital firm specializing in healthcare investments since 2015.
Location
Wanchai, Wan Chai, HK
Founded
2015
ORI Capital is a venture capital firm established in 2015, specializing in early-stage investments within the healthcare sector globally. The firm focuses on innovative biotech companies, particularly in diagnostics, drug delivery, and therapeutics targeting high-mortality diseases such as cancer, cardiovascular, and neurodegenerative conditions. ORI Capital typically invests in Series A and Series B rounds.
Notable portfolio companies include AffyImmune Therapeutics, Arterys, and Enable Injections, with significant funding raised across these ventures. The firm was founded by Simone Song, who brings extensive expertise and leadership to the team. ORI Capital's investment philosophy emphasizes supporting groundbreaking healthcare innovations with the potential to address critical medical needs. The firm also offers strategic guidance and industry connections to help portfolio companies achieve their growth objectives.
ORI Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
